Učitavanje...
Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats
BACKGROUND: Erythropoietin (EPO) is widely used in diabetic patients receiving hemodialysis. The role of EPO in glucose homeostasis remains unclear. Therefore, we investigated the effect of EPO on hyperglycemia in rats with type 1-like diabetes. METHODS: Rats with streptozotocin-induced type 1-like...
Spremljeno u:
| Izdano u: | Drug Des Devel Ther |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4902144/ https://ncbi.nlm.nih.gov/pubmed/27350742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S105867 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|